THE UTILITY OF KI-67 AS A PROGNOSTIC BIOMARKER IN PULMONARY NEUROENDOCRINE TUMOURS: PROTOCOL FOR A SYSTEMATIC REVIEW AND META-ANALYSIS

The utility of Ki-67 as a prognostic biomarker in pulmonary neuroendocrine tumours: protocol for a systematic review and meta-analysis

Introduction The omission of the immunohistochemical proliferation marker Ki-67 labelling index (henceforth, simply Ki-67) from the 2015 WHO classification system of pulmonary neuroendocrine tumours (Lung-NETs) as a prognostic and grading criterion remains controversial.This systematic review along with meta-analysis will be conducted to assess the

read more

Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California

Abstract Background Hepatitis C virus (HCV) genotype (GT) has become an important measure in the diagnosis and monitoring of HCV infection treatment.In the United States (U.S.) HCV GT 1 is reported as the most common infecting GT among chronically infected patients.In Europe, read more however, recent studies have suggested that the epidemiology of

read more